These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
352 related items for PubMed ID: 24854516
1. HPV genotype prevalence in Australian women undergoing routine cervical screening by cytology status prior to implementation of an HPV vaccination program. Tabrizi SN, Brotherton JM, Stevens MP, Condon JR, McIntyre P, Smith D, Garland SM, WHINURS group. J Clin Virol; 2014 Jul; 60(3):250-6. PubMed ID: 24854516 [Abstract] [Full Text] [Related]
2. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines. Monsonego J, Zerat L, Syrjänen K, Zerat JC, Smith JS, Halfon P. Vaccine; 2012 Jul 27; 30(35):5215-21. PubMed ID: 22713720 [Abstract] [Full Text] [Related]
3. Age and geographic variability of human papillomavirus high-risk genotype distribution in a large unvaccinated population and of vaccination impact on HPV prevalence. Carozzi F, De Marco L, Gillio-Tos A, Del Mistro A, Girlando S, Baboci L, Trevisan M, Burroni E, Grasso S, Giorgi Rossi P, Ronco G, NTCC Working Group. J Clin Virol; 2014 Jul 27; 60(3):257-63. PubMed ID: 24815381 [Abstract] [Full Text] [Related]
4. Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening. Učakar V, Poljak M, Oštrbenk A, Klavs I. J Med Virol; 2014 Oct 27; 86(10):1772-9. PubMed ID: 24978445 [Abstract] [Full Text] [Related]
5. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis. Gupta S, Sodhani P, Sharma A, Sharma JK, Halder K, Charchra KL, Sardana S, Singh V, Sehgal A, Das BC. Cytopathology; 2009 Aug 27; 20(4):249-55. PubMed ID: 19018810 [Abstract] [Full Text] [Related]
6. Decline in prevalence of human papillomavirus infection following vaccination among Australian Indigenous women, a population at higher risk of cervical cancer: The VIP-I study. McGregor S, Saulo D, Brotherton JML, Liu B, Phillips S, Skinner SR, Luey M, Oliver L, Stewart M, Tabrizi SN, Garland S, Kaldor JM. Vaccine; 2018 Jul 05; 36(29):4311-4316. PubMed ID: 29880245 [Abstract] [Full Text] [Related]
7. Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep Pap samples. Cibas ES, Hong X, Crum CP, Feldman S. Gynecol Oncol; 2007 Mar 05; 104(3):702-6. PubMed ID: 17150245 [Abstract] [Full Text] [Related]
8. Cervical high-risk human papillomavirus infection among women residing in the Gulf Cooperation Council countries: Prevalence, type-specific distribution, and correlation with cervical cytology. Ali MAM, Bedair RN, Abd El Atti RM. Cancer Cytopathol; 2019 Sep 05; 127(9):567-577. PubMed ID: 31390155 [Abstract] [Full Text] [Related]
9. Prevalence and genotype distribution of multiple human papillomavirus infection in the uterine cervix: a 7.5-year longitudinal study in a routine cytology-based screening population in West Germany. Kovács K, Varnai AD, Bollmann M, Bankfalvi A, Szendy M, Speich N, Schmitt C, Pajor L, Bollmann R. J Med Virol; 2008 Oct 05; 80(10):1814-23. PubMed ID: 18712836 [Abstract] [Full Text] [Related]
10. HPV genotype prevalence in women with abnormal pap smears in Melbourne, Australia. Stevens MP, Garland SM, Tan JH, Quinn MA, Petersen RW, Tabrizi SN. J Med Virol; 2009 Jul 05; 81(7):1283-91. PubMed ID: 19475612 [Abstract] [Full Text] [Related]
12. Automation of the linear array HPV genotyping test and its application for routine typing of human papillomaviruses in cervical specimens of women without cytological abnormalities in Switzerland. Dobec M, Bannwart F, Kaeppeli F, Cassinotti P. J Clin Virol; 2009 May 05; 45(1):23-7. PubMed ID: 19375383 [Abstract] [Full Text] [Related]
13. Prevalence of human papillomavirus in young Italian women with normal cytology: how should we adapt the national vaccination policy? Panatto D, Amicizia D, Tanzi E, Bianchi S, Frati ER, Zotti CM, Lai PL, Bechini A, Rossi S, Gasparini R. BMC Infect Dis; 2013 Dec 06; 13():575. PubMed ID: 24313984 [Abstract] [Full Text] [Related]
14. Human papillomavirus prevalence and cytopathology correlation in young Ugandan women using a low-cost liquid-based Pap preparation. Taube JM, Kamira B, Motevalli M, Nakabiito C, Lukande R, Kelly DP, Erozan YS, Gravitt PE, Buresh ME, Mmiro F, Bagenda D, Guay LA, Jackson JB. Diagn Cytopathol; 2010 Aug 06; 38(8):555-63. PubMed ID: 19937939 [Abstract] [Full Text] [Related]
16. Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy. Agarossi A, Ferrazzi E, Parazzini F, Perno CF, Ghisoni L. J Med Virol; 2009 Mar 06; 81(3):529-35. PubMed ID: 19152401 [Abstract] [Full Text] [Related]
17. Prevalence of human papillomavirus infection among women presenting for cervical cancer screening in Chile, 2014-2015. Balanda M, Quiero A, Vergara N, Espinoza G, Martín HS, Rojas G, Ramírez E. Med Microbiol Immunol; 2016 Dec 06; 205(6):585-594. PubMed ID: 27539577 [Abstract] [Full Text] [Related]
20. Human papillomavirus DNA detection in women with primary abnormal cytology of the cervix: prevalence and distribution of HPV genotypes. Beerens E, Van Renterghem L, Praet M, Sturtewagen Y, Weyers S, Temmerman M, Depypere H, Claeys P, Cuvelier CA. Cytopathology; 2005 Aug 06; 16(4):199-205. PubMed ID: 16048506 [Abstract] [Full Text] [Related] Page: [Next] [New Search]